BioWorld

Feb. 14, 2007

View Archived Issues

Omeros Raises $63M In Series E To Fund Broad Product Pipeline

Omeros Corp. set out to raise $20 million in its Series E financing round, but ended up bringing in more than $63 million by the time it was all over. (BioWorld Today) Read More

PDUFA Should Move Forward Unencumbered, BIO Advises

Read More

Pharmacopeia Gets $15M Up Front In Organon Deal

Read More

HGS Starts Phase III Trial With LymphoStat-B In Lupus

Read More

Cyclacel Raises $36M Through Direct Offering At Market Price

Read More

Locus Round Raises $30.2M To Push Cancer Drug, More

Read More

Other News To Note

Read More

Clinic Roundup

Read More